Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9,681 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immunological aspects of demyelinating diseases.
Martin R, McFarland HF, McFarlin DE. Martin R, et al. Annu Rev Immunol. 1992;10:153-87. doi: 10.1146/annurev.iy.10.040192.001101. Annu Rev Immunol. 1992. PMID: 1375472 Review.
Immunology of Multiple Sclerosis.
Sospedra M, Martin R. Sospedra M, et al. Semin Neurol. 2016 Apr;36(2):115-27. doi: 10.1055/s-0036-1579739. Epub 2016 Apr 26. Semin Neurol. 2016. PMID: 27116718 Review.
Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood--brain barrier disruption in multiple sclerosis.
Bielekova B, Richert N, Howard T, Packer AN, Blevins G, Ohayon J, McFarland HF, Stürzebecher CS, Martin R. Bielekova B, et al. Mult Scler. 2009 Oct;15(10):1206-14. doi: 10.1177/1352458509345903. Epub 2009 Sep 23. Mult Scler. 2009. PMID: 19776093 Free PMC article. Clinical Trial.
Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, Waldmann TA, McFarland H, Henkart PA, Martin R. Bielekova B, et al. Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5941-6. doi: 10.1073/pnas.0601335103. Epub 2006 Apr 3. Proc Natl Acad Sci U S A. 2006. PMID: 16585503 Free PMC article. Clinical Trial.
CD46 on glial cells can function as a receptor for viral glycoprotein-mediated cell-cell fusion.
Cassiani-Ingoni R, Greenstone HL, Donati D, Fogdell-Hahn A, Martinelli E, Refai D, Martin R, Berger EA, Jacobson S. Cassiani-Ingoni R, et al. Glia. 2005 Nov 15;52(3):252-8. doi: 10.1002/glia.20219. Glia. 2005. PMID: 15920733
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta.
Bielekova B, Richert N, Howard T, Blevins G, Markovic-Plese S, McCartin J, Frank JA, Würfel J, Ohayon J, Waldmann TA, McFarland HF, Martin R. Bielekova B, et al. Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8705-8. doi: 10.1073/pnas.0402653101. Epub 2004 May 25. Proc Natl Acad Sci U S A. 2004. PMID: 15161974 Free PMC article. Clinical Trial.
Development of biomarkers in multiple sclerosis.
Bielekova B, Martin R. Bielekova B, et al. Brain. 2004 Jul;127(Pt 7):1463-78. doi: 10.1093/brain/awh176. Epub 2004 Jun 4. Brain. 2004. PMID: 15180926 Review.
Hsp70 regulates immune response in experimental autoimmune encephalomyelitis.
Mansilla MJ, Costa C, Eixarch H, Tepavcevic V, Castillo M, Martin R, Lubetzki C, Aigrot MS, Montalban X, Espejo C. Mansilla MJ, et al. PLoS One. 2014 Aug 25;9(8):e105737. doi: 10.1371/journal.pone.0105737. eCollection 2014. PLoS One. 2014. PMID: 25153885 Free PMC article.
A molecular view of multiple sclerosis and experimental autoimmune encephalitis: what can we learn from the epitope data?
Vaughan K, Peters B, O'Connor KC, Martin R, Sette A. Vaughan K, et al. J Neuroimmunol. 2014 Feb 15;267(1-2):73-85. doi: 10.1016/j.jneuroim.2013.12.009. Epub 2013 Dec 12. J Neuroimmunol. 2014. PMID: 24365494 Free PMC article.
HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype.
Prat E, Tomaru U, Sabater L, Park DM, Granger R, Kruse N, Ohayon JM, Bettinotti MP, Martin R. Prat E, et al. J Neuroimmunol. 2005 Oct;167(1-2):108-19. doi: 10.1016/j.jneuroim.2005.04.027. J Neuroimmunol. 2005. PMID: 16111772
9,681 results
Jump to page